The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry
about
Temporary mechanical circulatory support: a review of the options, indications, and outcomesClinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database.Use of left ventricular support devices during acute coronary syndrome and percutaneous coronary intervention.Percutaneous Ventricular Assist Devices and ECMO in the Management of Acute Decompensated Heart Failure.Percutaneous assist devices in acute myocardial infarction with cardiogenic shock: Review, meta-analysisVentricular Assist Device in Acute Myocardial Infarction.Surgical revascularisation of the acute coronary artery syndrome.Health economics of percutaneous hemodynamic support in the treatment of high-risk cardiac patients: a systematic appraisal of the literature.Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.Management of cardiogenic shock.Percutaneous Mechanical Support in Cardiogenic Shock: A Review.Hemodynamic Support Devices for Shock and High-Risk PCI: When and Which One.Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: An analysis of the Medicare database.A retrospective analysis of Impella use in all-comers: 1-year outcomes.Acute mechanical circulatory support for cardiogenic shock: the "door to support" timePercutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock.Novel percutaneous mechanical circulatory support devices and their expanding applications.The Impella® Recover mechanical assist device in acute cardiogenic shock: a single-centre experience of 66 patients.Interventional therapies in acute myocardial infarction complicated by cardiogenic shock.Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.Physiological insights of recent clinical diagnostic and therapeutic technologies for cardiovascular diseases.Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory Support.Women With Cardiogenic Shock Derive Greater Benefit From Early Mechanical Circulatory Support: An Update From the cVAD Registry.Coronary Revascularization in Cardiogenic Shock.Successful Use of Surgically Placed Impella 5.0 and Central Extracorporeal Membrane Oxygenation Circuit in a Patient with Postcardiotomy Shock.Use of Impella 2.5 in Patient with Multi-Vessel Percutaneous Coronary Intervention and Cardiogenic Shock.Advancements in mechanical circulatory support for patients in acute and chronic heart failure.Gender difference with the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: From pVAD Working Group.Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative.Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock.Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight.Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials.The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.Integrating invasive hemodynamic parameters into risk stratification of acute myocardial infarction and cardiogenic shock.Editorial: Stop thinking and start acting: Early Impella placement associated with improved outcomes, again!Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock.[Left ventricular unloading in cardiogenic shock].Mechanical Circulatory Support in High-Risk Percutaneous Coronary Intervention.
P2860
Q26824537-674B3D0B-66C5-4C41-9173-FDA94E10F9D1Q31034537-02274B70-B67C-4E51-BFAE-C3B45EC6D52FQ34444090-7D30ED54-C9E0-49E6-86C1-491E75BEA7D0Q35545474-E28515E2-2687-427A-B64F-902E8EFFDA39Q36505924-B1F2C026-BA4F-466C-B339-4C2F390A4E9FQ36827910-34B1CDA0-8BF2-4476-B126-BABDC59D8766Q38189489-F876BB00-D2AF-4840-9009-CACA080A2CECQ38204771-3D6BF5E6-9952-416C-A026-98B30642870AQ38244795-8633EDBC-EEC3-43FA-8361-E334C81DF743Q38366956-AD8D2FEA-348E-4435-8F32-DECC8DC22BE7Q38519847-F2E14837-0877-4159-938C-ED5BE1439994Q38601021-E73455F5-DAA7-4673-9D1A-31B6CF09D558Q38628892-B0AAD02E-5C75-4E4C-A90A-9FAEDEF29AE1Q38665435-0F07ADCF-7E39-4ECE-8B99-EB94F5223EDBQ38674901-4F951ACA-ED0F-4993-857F-A3F4CE7B3B8CQ38788588-3E4236F0-246E-47F7-AA39-B2519174A2B4Q38906507-0D074C95-CDD6-42C2-A579-C418B9CF4571Q38921323-213B7F7E-6320-4394-BB75-6CE05A9A7164Q39026592-F5884997-72D1-4C7F-AADD-94288FC19527Q39283980-92923E9B-CE46-4DEF-9466-9E352638C94DQ39417436-284C0F9A-17BB-4ABD-B190-AD4A179094FEQ39457136-037E7322-E251-4CFA-9D5F-000DACD4066FQ39733608-2B5B4362-C21E-4872-8D43-3E3CD7CA1638Q40169143-8A5CCDA8-ED15-422B-806A-EF24AC93DEE9Q41974886-1470C8C7-67CE-4933-AF16-0BCFC7C07390Q42367048-CD4BC682-DD81-4CEB-8996-546CD1F8F350Q47097098-69DF5478-649C-4460-8351-AA732ACECDE9Q47195078-E4A803BA-1410-4CDA-964B-0908A38A3B68Q47228661-8E19F4AF-6D9C-4E55-BE94-091FF55A4D04Q47388957-7B027828-34E0-447E-B881-1FA7020DC24AQ47552537-F4CEFA8E-5DBC-4694-A6AA-1B15D4C2A15DQ47579858-53C3586F-5C38-4711-9114-60CBD0CE2EFFQ47642907-B997F56A-D2B1-47BB-8E1C-B5EAB71035BDQ48096926-475B1DD1-E3AF-44B9-B20C-A2B714C76E6AQ48202373-7E1F89F6-3C2C-4F55-B96E-642E758AAD87Q49927564-2FB910D4-EBD9-4E68-8297-465869E4744AQ51023449-5BA593AB-07AA-4B2F-95EB-06BD829CC15EQ55362302-FC13E4F0-5920-4C09-83B1-D70F63160634
P2860
The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The current use of Impella 2.5 ...... ults from the USpella Registry
@ast
The current use of Impella 2.5 ...... ults from the USpella Registry
@en
The current use of Impella 2.5 ...... ults from the USpella Registry
@nl
type
label
The current use of Impella 2.5 ...... ults from the USpella Registry
@ast
The current use of Impella 2.5 ...... ults from the USpella Registry
@en
The current use of Impella 2.5 ...... ults from the USpella Registry
@nl
prefLabel
The current use of Impella 2.5 ...... ults from the USpella Registry
@ast
The current use of Impella 2.5 ...... ults from the USpella Registry
@en
The current use of Impella 2.5 ...... ults from the USpella Registry
@nl
P2093
P2860
P356
P1476
The current use of Impella 2.5 ...... ults from the USpella Registry
@en
P2093
Andrew B Civitello
Brijeshwar Maini
Charanjit Rihal
David H W Wohns
Joseph M Massaro
Simon R Dixon
Srihari S Naidu
Theodore Schreiber
William W O'Neill
P2860
P356
10.1111/JOIC.12080
P577
2013-12-13T00:00:00Z